BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6637470)

  • 1. The renin-aldosterone system in nephrogenic diabetes insipidus and the influence of hydrochlorothiazide and indomethacin.
    Andersen O; Jacobsen BB
    Acta Paediatr Scand; 1983 Sep; 72(5):717-20. PubMed ID: 6637470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative therapeutic benefit of indomethacin, hydrochlorothiazide, and acetyl-salicylic acid in a patient with nephrogenic diabetes insipidus.
    Vierhapper H; Jörg J; Favre L; Vallotton MB; Waldhäusl W
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):311-6. PubMed ID: 6588700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin.
    Rascher W; Rosendahl W; Henrichs IA; Maier R; Seyberth HW
    Pediatr Nephrol; 1987 Jul; 1(3):485-90. PubMed ID: 3153321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus.
    Monnens L; Jonkman A; Thomas C
    Clin Sci (Lond); 1984 Jun; 66(6):709-15. PubMed ID: 6723207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus.
    Jakobsson B; Berg U
    Acta Paediatr; 1994 May; 83(5):522-5. PubMed ID: 8086732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with hydrochlorothiazide and amiloride in an infant with congenital nephrogenic diabetes insipidus.
    Uyeki TM; Barry FL; Rosenthal SM; Mathias RS
    Pediatr Nephrol; 1993 Oct; 7(5):554-6. PubMed ID: 8251321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus.
    Knoers N; Monnens LA
    J Pediatr; 1990 Sep; 117(3):499-502. PubMed ID: 2391611
    [No Abstract]   [Full Text] [Related]  

  • 8. Nephrogenic diabetes insipidus: clinical and pathophysiological aspects.
    Niaudet P; Dechaux M; Trivin C; Loirat C; Broyer M
    Adv Nephrol Necker Hosp; 1984; 13():247-60. PubMed ID: 6089520
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term course of 6 boys with congenital nephrogenic diabetes insipidus].
    Kaulitz R; Brodehl J
    Klin Padiatr; 1989; 201(6):425-30. PubMed ID: 2601280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus.
    Alon U; Chan JC
    Am J Nephrol; 1985; 5(1):9-13. PubMed ID: 3970081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of 7 patients with gestational diabetes insipidus].
    Wu LQ; Xiong CQ; Wu M; Dong RL; Chen YQ; Gao J; Chen OJ; Huang YP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):266-8. PubMed ID: 18843966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrogenic diabetes insipidus. Radiological and clinical features.
    Hartenberg MA; Cory M; Chan JC
    Int J Pediatr Nephrol; 1985; 6(4):281-6. PubMed ID: 4093246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital nephrogenic diabetes insipidus with bilateral hydronephrosis: indomethacin in treatment of nephrogenic diabetes insipidus.
    Sohn YM; Lee C; Kim PK; Yun DJ
    Yonsei Med J; 1980; 21(2):116-22. PubMed ID: 7314648
    [No Abstract]   [Full Text] [Related]  

  • 14. Nephrogenic diabetes insipidus: treat with caution.
    Boussemart T; Nsota J; Martin-Coignard D; Champion G
    Pediatr Nephrol; 2009 Sep; 24(9):1761-3. PubMed ID: 19373493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of prostaglandin synthesis during the therapy of nephrogenic diabetes insipidus].
    Stögmann W; Bohrn E
    Wien Klin Wochenschr; 1984 Jan; 96(1):12-6. PubMed ID: 6710993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride.
    Kirchlechner V; Koller DY; Seidl R; Waldhauser F
    Arch Dis Child; 1999 Jun; 80(6):548-52. PubMed ID: 10332005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrogenic diabetes insipidus and obstructive uropathy.
    Wiggelinkhuizen J; Retief PJ; Wolff B; Fisher RM; Cremin BJ
    Am J Dis Child; 1973 Sep; 126(3):398-401. PubMed ID: 4746552
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial ADH-responsive diabetes insipidus: response to thiazides and chlorpropamide.
    Driedger AA; Linton AL
    Can Med Assoc J; 1973 Oct; 109(7):594-7. PubMed ID: 4742488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical management of postobstructive polyuria.
    Smoyer WE
    Am J Dis Child; 1991 Dec; 145(12):1345-8. PubMed ID: 1669655
    [No Abstract]   [Full Text] [Related]  

  • 20. Desmopressin and indomethacin therapy for nephrogenic diabetes insipidus in patients receiving lithium carbonate.
    Weinstock RS; Moses AM
    South Med J; 1990 Dec; 83(12):1475-7. PubMed ID: 2123565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.